Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James A Russell, MD
University of British Columbia
Principal Investigator - Karen Tran, MD
University of British Columbia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary - Foothills
Calgary, Alberta, Canada
- Royal Jubilee Hospital
Nanaimo, British Columbia, Canada
- Surrey Memorial Hospital
Surrey, British Columbia, Canada
- St Paul'S Hospital
Vancouver, British Columbia, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- the Ottawa Hospital
Ottawa, Ontario, Canada
- Niagara Health
Saint Catharines, Ontario, Canada
- St Michael'S Hospital
Toronto, Ontario, Canada
- Sunnybrook Hospital
Toronto, Ontario, Canada
- Chu de Québec - Université Laval
Laval, Quebec, Canada
- Mcgill University Health Center
Montreal, Quebec, Canada
- Université de Sherbrooke
Sherbrooke, Quebec, Canada
- Centre Hospitalier Universitaire D'Angers
Angers, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Oct 2020
- Primary completion
- 22 Apr 2022
- Completion
- 22 Apr 2022
- Last update posted
- 16 Feb 2023
- Registered enrollment
- 341
- Registry id
- NCT04606563
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.